期刊文献+

哮喘患者气传昆虫变应原疫苗的实验 被引量:5

Study of airborne insect allergen in asthmatic patients
下载PDF
导出
摘要 目的 :研究西安地区哮喘患者气传致敏昆虫变应原种类 ,为哮喘病因学研究及防治提供实验依据 .方法 :制备 13种气传优势昆虫变应原疫苗 ,应用这些昆虫变应原疫苗给哮喘患者 30 0例和正常对照者 10 0例分别做皮肤挑刺试验(SPT) ,及应用BSA ELISA法测定昆虫SPT阳性患者的sIgE .结果 :哮喘患者 30 0例气传昆虫变应原疫苗SPT总阳性率为 6 0 % ,显著高于正常对照 (P <0 .0 1) ;哮喘组患者对粉蝶、棉铃虫、霜天蛾等 10种气传昆虫变应原疫苗的SPT阳性率在 30 %以上 ;SPT阳性的哮喘患者气传昆虫变应原sIgE阳性率达 85 %以上 ,对照组仅为 6 % ,两组之间有显著性差异 (P<0 .0 1) .结论 :粉蝶、棉铃虫、霜天蛾等 10种气传昆虫是西安地区哮喘的主要气传致敏昆虫 ,可能是夏末秋初哮喘发作的致敏原 . AIM: To study the variety of airborne allergic insects and its irritability in asthmatic patients in Xi’an area and to provide experimental gist for etiological study and prevention of asthma. METHODS: Three hundred asthmatic patients and 100 normal controls underwent skin prick test (SPT) with 13 kinds of superior airborne insect vaccine, and sera sIgE of those with positive SPT results were tested by BSA-ELISA. RESULTS: The positivity rate of SPT with the 13 kinds of insect vaccine in asthmatic patients was 60%, significantly higher than that in normal controls (P<0.01). The positivity rate of SPT with Stayridae, Heliothis armigera, Psilgramma menephorn and other 7 kinds of insects were more than 30% in asthmatic patients, indicating that these 10 kinds of insects were the main allergic insects in asthmatic patients. The positivity rate of sIgE in asthmatic patients was more than 85%, significantly higher than that in normal control’s (6%, P<0.01). CONCLUSION: Stayridae, Heliothis armigera, Psilgramma menephorn and other 7 kinds of insects may be the main allergic insects in asthmatic patients in Xi’an area and maybe be the main allergens to the onset of asthma in the end summer and the early autumn.
出处 《第四军医大学学报》 CAS 北大核心 2004年第19期1813-1815,共3页 Journal of the Fourth Military Medical University
  • 相关文献

参考文献2

共引文献3561

同被引文献33

  • 1刘志刚,黄炯烈,朱振宇,周珍文,刘玉琳,龚十妹.美洲大蠊若虫cDNA表达文库的构建和初步鉴定[J].中华微生物学和免疫学杂志,2001,21(S2):9-11. 被引量:21
  • 2陈欢,刘光辉,祝戎飞.武汉地区支气管哮喘患者常见吸入变应原调查[J].临床内科杂志,2004,21(11):785-786. 被引量:45
  • 3孙秀珍,刘昀.霜天蛾cDNA表达文库的构建和初步鉴定[J].西安交通大学学报(医学版),2005,26(3):244-246. 被引量:11
  • 4Martin C,Alisa R.Recombinant allergen for diagnosis and therapy of allergic disease[J].J Allergy Clin Immunol,2000,6(3):409-418.
  • 5WHO Position Paper.Allergen immunotherapy:the therapeutic vaccines for allergic diseases[J].Eur J Allergy Clin Immunol Allergy,1998,53(Suppl44):1.
  • 6Cantani A,Arcese G,Lucenti P,et al.A three-year prospective study of specific immunotherapy to inhalant allergens:evidence of safety and efficacy in 300 children with allergic asthma[J].J Invest Allergol Clin Immunol,1997,7(2):90-97.
  • 7Campbell D,De Kruyff RH,Umetsu DT.Allergen immunotherapy:novel approaches in the management of allergic diseases and asthma[J].Clin Immunol,2000,97:193-202.
  • 8Rudolf V,Dietrich K.From allergen structure to new forms of allergen-specific immunotherapy[J].Current Opin Immunol,2002,14:718-727.
  • 9Rober NR,Harod SN,Ira F.Effectiveness of specific immunotherapy in the treatment of asthma[J].Chin Ther,2000,2:329-341.
  • 10Dewitt AM,Andersson K,Peltre G,et al.Cloning,expression and immunological characterization of full-length timothy grass pollen allergen Phl p 4,a berberine bridge enzyme-like protein with homology to celery allergen Api g 5[J].Clin Exp Allergy,2006,36(1):77-86.

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部